CLINICAL_TRIALS
trial_result
· 2015-05-27
Clinical Trial Update: Detection of PPROM With AmniSure PAMG-1 Rapid Immunoassay
Summary
A terminated clinical trial evaluated the AmniSure PAMG-1 rapid immunoassay for detecting preterm premature rupture of fetal membranes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Saskatchewan | Conditions: Preterm Premature Rupture of Fetal Membranes | Status: TERMINATED